Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.
Busse, William W
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. [electronic resource] - American journal of respiratory and critical care medicine Dec 2013 - 1294-302 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1535-4970
10.1164/rccm.201212-2318OC doi
Adolescent
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Asthma--drug therapy
Bronchi--drug effects
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Receptors, Interleukin-17--antagonists & inhibitors
Young Adult
Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma. [electronic resource] - American journal of respiratory and critical care medicine Dec 2013 - 1294-302 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1535-4970
10.1164/rccm.201212-2318OC doi
Adolescent
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Asthma--drug therapy
Bronchi--drug effects
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Male
Middle Aged
Receptors, Interleukin-17--antagonists & inhibitors
Young Adult